How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

1,267 results for

Long-Acting Reversible Contraception

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

121. Contraceptive use among women with cystic fibrosis: A pilot study linking reproductive health questions to the Cystic Fibrosis Foundation National Patient Registry. Full Text available with Trip Pro

findings were merged with retrospective clinical information from the CF Foundation Patient Registry (CFFPR). We used descriptive analyses to report contraceptive method and pregnancy frequencies, and logistic regression to examine the association between contraceptive method type and adverse health outcomes.Combined hormonal contraceptives were the most commonly used methods (42%), followed by condoms (34%), and long-acting reversible contraceptives methods (27%). Thirty-three percent (n = 50 (...) Contraceptive use among women with cystic fibrosis: A pilot study linking reproductive health questions to the Cystic Fibrosis Foundation National Patient Registry. To examine contraceptive use, pregnancy intention and the association of hormonal contraceptive type with adverse health outcomes among women with cystic fibrosis (CF).We recruited 150 women with CF, ages 18-49 from three adult CF programs to complete an online survey regarding their pregnancy and contraceptive use history. Survey

2020 Contraception

122. The effects of CenteringPregnancy group prenatal care on postpartum visit attendance and contraception use. Full Text available with Trip Pro

propensity score methods to identify a comparison group, accounting for the nested data structure by practice. We examined five standardized, claims-based outcomes: postpartum visit attendance; contraception within 3 days; and any contraception, long-acting reversible contraception (LARC), and permanent contraception within eight weeks. We assessed outcomes using logistic regression for two treatment levels: (1) any group attendance compared to no group attendance and (2) attendance at five or more group (...) visit attendance.Planning for postpartum care and contraception during prenatal care is an important strategy for connecting women to postpartum healthcare. Regardless of prenatal care model, women have low uptake of contraception in the postpartum period. Increased use of group prenatal care with its scheduled family planning discussion may help to increase postpartum contraceptive uptake. This benefit is dependent on availability of postpartum contraception options.Copyright © 2020 Elsevier Inc

2020 Contraception

123. The effect of a no-cost contraceptive initiative on method selection by women with housing insecurity. Full Text available with Trip Pro

, regardless of housing security. Contraceptive clients in this vulnerable population need interventions which address access barriers to all methods to support reproductive planning.Unintended pregnancy during housing insecurity may result in homelessness. This study found housing-insecure women desire access to all contraceptive methods, not just long acting reversible contraception. Integration of comprehensive family planning initiatives into efforts to address homelessness is essential to support (...) -insecure participants. Compared to those with stable housing, housing-insecure individuals more commonly identified as a sexual minority, received public assistance and lacked health insurance. Housing-insecure women preferentially selected long-acting reversible contraception during the control period (aOR 1.60; 95%CI 1.01-2.56), but method selection equalized across housing status during the intervention.When cost is not a barrier, all women desire a comprehensive selection of contraceptive methods

2020 Contraception

124. Contraceptive use and reproductive intentions among women requesting contraceptive counseling. Full Text available with Trip Pro

life planning (before randomization). Women requesting contraceptive counseling answered questions about contraception and whether they wanted to have children/more children in the future.In total, 1946 women participated: 33.7% (n = 656) parous and 65.7% (n = 1279) nulliparous. The majority, 87.1% (n = 1682), had used contraception during their latest intercourse; 64.6% (n = 1239) used short-acting reversible contraception, 22.8% (n = 443) used long-acting reversible contraception (LARC), and 12.9 (...) Contraceptive use and reproductive intentions among women requesting contraceptive counseling. Limited attention has been paid to the use of contraception in relation to women's family planning intentions. The aim of this study was to investigate the use of contraception during the most recent intercourse as well as the reproductive intentions of Swedish-speaking women requesting contraceptive counseling.A cross-sectional baseline survey in a randomized controlled trial regarding reproductive

2018 Acta Obstetricia et Gynecologica Scandinavica

125. Mobile contraceptive application use in a clinical setting in addition to standard contraceptive counseling: a randomized controlled trial. (Abstract)

Mobile contraceptive application use in a clinical setting in addition to standard contraceptive counseling: a randomized controlled trial. To evaluate the effect of miPlan, a waiting-room contraceptive counseling mobile application (app), on interest in discussing long-acting reversible contraception (LARC) during the clinical encounter and LARC uptake.This randomized controlled trial evaluated the miPlan contraceptive counseling app. African American and Latina young women ages 15-29 years (...) attending four family planning clinics in a large Midwestern city were randomized to either: (1) use miPlan (intervention) prior to the contraceptive clinic visit or (2) contraceptive clinic visit alone (control). Groups were compared on knowledge of contraceptive effectiveness, interest in discussing LARC, behavioral intentions to use LARC, and LARC uptake.From February 2015 to January 2016, 207 young women were randomized to intervention (n=104) or control (n=103) group. Immediately following app use

2018 Contraception Controlled trial quality: uncertain

126. Assessment of Cultural Acceptability of Long Acting Contraception in a Diverse, Urban Population

topics: Arms and Interventions Go to Arm Intervention/treatment Experimental: Intervention arm Participants in the intervention arm will be asked to watch a short educational video on LARC (Long acting reversible contraceptive) and to complete a survey before and after watching the video. Behavioral: Educational video on LARC Participants will watch a short educational video on long acting reversible contraceptive or LARC No Intervention: Control arm Participants in the intervention arm will only (...) Assessment of Cultural Acceptability of Long Acting Contraception in a Diverse, Urban Population Assessment of Cultural Acceptability of Long Acting Contraception in a Diverse, Urban Population - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one

2018 Clinical Trials

127. Unplanned pregnancies and contraceptive use among HIV- positive women in care. Full Text available with Trip Pro

years at time of interview, we computed weighted prevalences of contraceptive use (previous 12 months) by method, including permanent (i.e., sterilization), short-acting (i.e., pills, depo-progesterone acetate (DMPA)), long-acting reversible contraceptives (LARC) (i.e., implants), and barriers (i.e., condoms). Six hundred seventy-one women met criteria for the unplanned pregnancy analysis; median age at HIV diagnosis = 24.6 years, and 78.1% (CI:74.5-81.7) reported ≥ 1 unplanned pregnancy. Women (...) Unplanned pregnancies and contraceptive use among HIV- positive women in care. Among 230,360 women with diagnosed HIV in the United States (U.S.), ~ 8,500 give birth annually, and unplanned pregnancies (as with HIV-negative women) are prevalent. However, unplanned pregnancies and contraceptive use among HIV-positive women have been understudied. To examine unplanned pregnancies and contraceptive use among HIV-positive women, we used 2013-2014 data from the Medical Monitoring Project (MMP

2018 PLoS ONE

128. Clinical effectiveness of Etonorgestrel Contraceptive Implant (Nexplanon/Implanon-NXT) as compared to other Long Acting Reversible Contraceptive (LARC) methods and female sterilization in women of reproductive age group

Clinical effectiveness of Etonorgestrel Contraceptive Implant (Nexplanon/Implanon-NXT) as compared to other Long Acting Reversible Contraceptive (LARC) methods and female sterilization in women of reproductive age group Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any

2018 PROSPERO

129. Cohort study: Initiation of long-acting reversible contraceptive methods (IUDs and implant) at pregnancy termination reduces repeat abortion

Cohort study: Initiation of long-acting reversible contraceptive methods (IUDs and implant) at pregnancy termination reduces repeat abortion Initiation of long-acting reversible contraceptive methods (IUDs and implant) at pregnancy termination reduces repeat abortion | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please (...) see our . Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Initiation of long-acting reversible contraceptive methods (IUDs and implant) at pregnancy termination reduces repeat

2013 Evidence-Based Medicine

130. Contraception During Breastfeeding

in breastfeeding women. 45 A recent systematic review suggested that IUDs ABM PROTOCOL 7 remain a long-acting reversible contraceptive option for breastfeeding women with cesarean birth. 46 Irreversible options (sterilization) Multiple methods of surgical sterilization are available, including male vasectomy, postpartum tubal ligation, lapa- roscopic tubal ligation, and hysteroscopic tubal occlusion. These procedures involve different technologies, surgical techniques, anesthesia, and procedural settings (...) - ance on the lactational amenorrhea method (LAM). Thisprotocolassumesthatthepractitioneriswellversedin the risks and bene?ts of different types of contraception, in- cluding all pharmaceutical, permanent, and periodic absti- nence/natural family planning methods. Issues in Counseling and Selection of Contraceptives During Breastfeeding 1. Considerations for clinician counseling and method use Postpartum contraception, like breastfeeding, should be discussed with women during their own obstetric

2015 Academy of Breastfeeding Medicine

131. Medical eligibility criteria for contraceptive use

contraception POCs Patch Male surgical sterilization Ring ECPs COCs Barrier methods IUDs Fertility awareness-based methods Lactational Coitus interruptus Copper IUD for amenorrhoea Patch Female surgical sterilization Intrauterine devices CICs emergency contraception POCs Patch Male surgical sterilization Ring ECPs A WHO family planning cornerstone Medical eligibility criteria for contraceptive use Fifth edition ISBN 978 92 4 1549158 Fifth edition, 2015 Medical eligibility criteria for contraceptive (...) useMedical eligibility criteria for contraceptive use Fifth edition 2015WHO Library Cataloguing-in-Publication Data Medical eligibility criteria for contraceptive use -- 5th ed. 1.Contraception – methods. 2.Family Planning Services. 3.Eligibility Determination – standards. 4.Quality Assurance, Health Care. 5.Health Services Accessibility. I.World Health Organization. ISBN 978 92 4 154915 8 (NLM classification: WP 630) © World Health Organization 2015 All rights reserved. Publications of the World Health

2015 World Health Organisation Guidelines

132. Access to Contraception

provision of contraception, including reimbursement for long-acting reversible contraception (LARC) devices separate from the global fee for delivery, and coverage for contraceptive care and contraceptive methods provided on the same day as an abortion procedure Inclusion of all contraceptive methods, including LARC, on all payer and hospital formularies Funding for research to identify effective strategies to reduce health inequities in unintended pregnancy and access to contraception Background (...) 101. Washington, DC: NWLC; 2011. Available at: . Retrieved August 4, 2014. American Pharmacists Association. Pharmacist conscience clause. Washington, DC: APhA; 2004. Available at: . Retrieved August 4, 2014. Stewart FH, Harper CC, Ellertson CE, Grimes DA, Sawaya GF, Trussell J. Clinical breast and pelvic examination requirements for hormonal contraception: Current practice vs evidence. JAMA 2001;285:2232–9. [ ] [ ] Adolescents and long-acting reversible contraception: implants and intrauterine

2015 American College of Obstetricians and Gynecologists

133. Increasing Access to Contraceptive Implants and Intrauterine Devices to Reduce Unintended Pregnancy

and user dependence from the effectiveness equation (see and ). These top-tier methods share the highest continuation rates of all contraceptives, which is one of the most important factors in contraceptive success (2). Fig. 1. Effectiveness of birth control methods.* Abbreviations: HIV, human immunodeficiency virus; IUD, intrauterine device; STIs, sexually transmitted infections. *Percentage of women who will become pregnant within the first year of typical use of the method. Long-Acting Reversible (...) Increasing Access to Contraceptive Implants and Intrauterine Devices to Reduce Unintended Pregnancy Increasing Access to Contraceptive Implants and Intrauterine Devices to Reduce Unintended Pregnancy - ACOG Menu ▼ Increasing Access to Contraceptive Implants and Intrauterine Devices to Reduce Unintended Pregnancy Page Navigation ▼ Number 642, October 2015 (Replaces Committee Opinion Number 450, December 2009) (Reaffirmed 2018) Committee on Gynecologic Practice Long-Acting Reversible

2015 American College of Obstetricians and Gynecologists

134. Emergency Contraception

an effective long-term method. Information regarding effective long-term contraceptive methods should be made available whenever a woman requests emergency contraception, and consideration should be given to the use of the copper IUD, which is highly effective as an emergency contraceptive and an ongoing contraceptive. Use of highly effective long-acting reversible methods should be encouraged. Is emergency contraception safe if used repeatedly? Data are not available on the safety of current regimens (...) Education Pamphlet APl14. Washington, DC: American College of Obste­tricians and Gynecologists;2013. Long-acting reversible contraception: implants and intrauterine devices. Practice Bulletin No. 121. American College of Obstetricians and Gynecologists. . Understanding and using the U.S. Medical Eligibility Criteria for Contraceptive Use, 2010. Committee Opin­ion No. 505. American College of Obstetricians and Gynecologists. . Understanding and using the U.S. Selected Practice Recommendations

2015 American College of Obstetricians and Gynecologists

135. Ensuring human rights in the provision of contraceptive information and services

routinely into contraceptive programmes. 5.2 Recommend that provision of long-acting reversible contraception (LARC) methods should include insertion and removal services, and counselling on side-effects, in the same locality. 5.3 Recommend ongoing competency-based training and supervision of health-care personnel on the delivery of contraceptive education, information and services. Competency-based training should be provided according to existing WHO guidelines. Informed decision-making 6.1 Recommend (...) Ensuring human rights in the provision of contraceptive information and services Ensuring human rights in the provision of contraceptive information and servicesEnsuring human rights in the provision of contraceptive information and services Guidance and recommendationsWHO Library Cataloguing-in-Publication Data Ensuring human rights in the provision of contraceptive information and services: guidance and recommendations. 1.Contraception. 2.Family Planning Services. 3.Human Rights. 4.Guideline

2015 World Health Organisation Guidelines

136. Integrating postpartum contraceptive counseling and IUD insertion services into maternity care in Nepal: results from stepped-wedge randomized controlled trial. Full Text available with Trip Pro

Integrating postpartum contraceptive counseling and IUD insertion services into maternity care in Nepal: results from stepped-wedge randomized controlled trial. In Nepal, 54% of women have an unmet need for family planning within the 2 years following a birth. Provision of a long-acting and reversible contraceptive method at the time of birth in health facilities could improve access to postpartum family planning for women who want to space or limit their births. This paper examines the impact (...) of an intervention that introduced postpartum contraceptive counseling in antenatal care and immediate postpartum intra-uterine device (PPIUD) insertion services following institutional delivery, with the intent to eventually integrate PPIUD counseling and insertion services as part of routine maternity care in Nepal.This study took place in six large tertiary hospitals. All women who gave birth in these hospitals in the 18-month period between September 2015 and March 2017 were asked to participate. A total

2019 Reproductive health Controlled trial quality: uncertain

137. Contraceptive use and childbirth rates by service branch during the first 24 months on active duty in the United States military from 2013 to 2018: a retrospective cohort analysis. (Abstract)

to reproductive health education and access to contraception during basic training differ by military branch. Highly effective contraception use (pills, patch, ring, shot, implants or intrauterine contraception) at 6 months on active duty [Army (18.1%), Air Force (27.4%), Marines (26.5%) and Navy (37.6%), p<.001], long-acting reversible contraceptive method use (implant or intrauterine) at 6 months [Army (2.0%), Air Force (3.7%), Marines (11.0%) and Navy (19.6%), p<.001] and childbirth in the first 24 months (...) Contraceptive use and childbirth rates by service branch during the first 24 months on active duty in the United States military from 2013 to 2018: a retrospective cohort analysis. To measure the association of military branch-specific contraceptive education and access policy during basic training with contraceptive use and childbirth among new recruits.Secondary analysis of insurance records from 92,072 active duty servicewomen who started basic training between 2013 and 2017.Exposure

2019 Contraception

138. Contraceptive use by women across different sexual orientation groups. (Abstract)

were the least likely of all sexual orientation groups to use any contraceptive method. Lesbians in NHS2 were 90% less likely than heterosexuals to use long-acting reversible contraceptives (LARCs; adjusted risk ratio [aRR]; 95% confidence interval [CI]: 0.10 [0.04, 0.26]) and results were similar for other contraceptive methods and in the NHS3 cohort. Compared to the reference group of completely heterosexual participants with no same-sex partners, those who identified as completely heterosexual (...) Contraceptive use by women across different sexual orientation groups. To examine contraceptive methods used across sexual orientation groups.We collected data from 118,462 female participants in two longitudinal cohorts-the Nurses' Health Study (NHS) 2 (founded in 1989, participants born 1947-1964) and NHS3 (founded in 2010, born 1965-1995). We used log-binomial models to estimate contraceptive methods ever used across sexual orientation groups and cohorts, adjusting for age and race.Lesbians

2019 Contraception

139. Comparison of unintended pregnancy at 12 months between two contraceptive care programs; a controlled time-trend design. (Abstract)

Comparison of unintended pregnancy at 12 months between two contraceptive care programs; a controlled time-trend design. To compare unintended pregnancy rates at 12 months between women receiving structured contraceptive counseling plus usual contraceptive care and women receiving structured contraceptive counseling, healthcare provider education and cost support for long-acting reversible contraceptive (LARC) methods.Using a controlled time-trend study design, we first enrolled 502 women (...) ; cost support; and on-the-shelf, long-acting reversible contraception can reduce unintended pregnancy compared to contraceptive counseling in addition to usual health center care in the FQHC setting.Copyright © 2019 Elsevier Inc. All rights reserved.

2019 Contraception Controlled trial quality: uncertain

140. Contraceptive method switching among women living in sub-Saharan Africa participating in an HIV-1 prevention trial: a prospective cohort study. (Abstract)

Contraceptive method switching among women living in sub-Saharan Africa participating in an HIV-1 prevention trial: a prospective cohort study. Long-acting reversible contraceptive (LARC) method uptake has been low within the context of HIV prevention trials. Within a multinational study (MTN-020/ASPIRE), the Contraceptive Action Team improved LARC accessibility and uptake. In this secondary analysis, we determined the rate of contraceptive method continuation among the women enrolled.ASPIRE (...) was a randomized, double-blinded, placebo-controlled phase III safety and effectiveness study of the Dapivirine Vaginal Ring for HIV-1 prevention. Between 2012 and 2014, sexually active women aged 18-45 from Malawi, South Africa, Uganda and Zimbabwe were enrolled. All participants were required to use contraception for enrollment to the study and could choose between all highly effective contraceptive methods available in their respective countries. Women were seen monthly and could change methods at any time

2019 Contraception Controlled trial quality: predicted high

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>